NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02267343,Study of ONO-4538 in Unresectable Advanced or Recurrent Gastric Cancer,https://clinicaltrials.gov/study/NCT02267343,,COMPLETED,The purpose of study is to evaluate the efficacy and safety of ONO-4538 in patients with unresectable advanced or recurrent gastric cancer (including esophagogastric junction cancer) refractory to or intolerant of standard therapy.,NO,Gastric Cancer,DRUG: ONO-4538|DRUG: Placebo,"Overall survival, Up to study completion (estimated time frame: 30 months), every 2 weeks in principle","Progression-free survival, Up to study completion (estimated time frame: 30 months), every 2 weeks in principle|Objective response rate, Up to study completion (estimated time frame: 30 months), every 6 weeks in principle|Duration of response, Up to study completion (estimated time frame: 30 months), every 6 weeks in principle|Safety will be analyzed through the incidence of adverse events, serious adverse events, Continuously throughout study treatment and up to 28 days from last dose|Safety will be analyzed through the incidence of laboratory abnormalities, Continuously throughout study treatment and up to 28 days from last dose",,Ono Pharmaceutical Co. Ltd,,ALL,"ADULT, OLDER_ADULT",PHASE3,493,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",ONO-4538-12,2014-10,2016-08,2021-01,2014-10-17,,2024-05-03,"Aichi Clinical Site, Nagoya, Aichi, 464-8681, Japan|Aomori Clinical Site, Misawa, Aomori, 033-0022, Japan|Ehime Clinical Site, Matsuyama, Ehime, 791-0280, Japan|Hokkaido Clinical Site, Sapporo, Hokkaido, 060-8648, Japan|Hyogo Clinical Site, Akashi, Hyogo, 673-8558, Japan|Hyogo Clinical Site, Kobe, Hyogo, 650-0047, Japan|Ishikawa Clinical Site, Kanazawa, Ishikawa, 920-8641, Japan|Kanagawa Clinical Site, Kawasaki, Kanagawa, 216-8511, Japan|Kanagawa Clinical Site, Sagamihara, Kanagawa, 252-0375, Japan|Kanagawa Clinical Site, Yokohama, Kanagawa, 241-8515, Japan|Nagano Clinical Site, Saku, Nagano, 385-0051, Japan|Osaka Clinical Site, Osakasayama, Osaka, 589-8511, Japan|Osaka Clinical Site, Suita, Osaka, 565-0871, Japan|Osaka Clinical Site, Takatsuki, Osaka, 569-8686, Japan|Saitama Clinical Site, Kitaadachi, Saitama, 362-0806, Japan|Shizuoka Clinical Site, Sunto-gun, Shizuoka, 411-8777, Japan|Tochigi Clinical Site, Shimotsuke, Tochigi, 329-0498, Japan|Tokyo Clinical Site, Bunkyo-ku, Tokyo, 113-8677, Japan|Tokyo Clinical Site, Chuo-ku, Tokyo, 104-0045, Japan|Tokyo Clinical Site, Koto-ku, Tokyo, 135-8550, Japan|Tokyo Clinical Site, Shinjuku-ku, Tokyo, 160-8582, Japan|Chiba Clinical Site, Chiba, 260-8717, Japan|Fukuoka Clinical Site, Fukuoka, 811-1395, Japan|Fukuoka Clinical Site, Fukuoka, 812-8582, Japan|Gifu Clinical Site, Gifu, 501-1194, Japan|Hiroshima Clinical Site, Hiroshima, 730-8518, Japan|Osaka Clinical Site, Osaka, 537-8511, Japan|Shizuoka Clinical Site, Shizuoka, 420-8527, Japan|Busan-si Clinical Site, Busan-si, 602-715, Korea, Republic of|Daegu Clinical Site, Daegu, 702-210, Korea, Republic of|Gyeonggi-Do Clinical Site, Gyeonggi-Do, 410-769, Korea, Republic of|Gyeonggi-Do Clinical Site, Gyeonggi-Do, 463-707, Korea, Republic of|Seoul Clinical Site, Seoul, 110-744, Korea, Republic of|Seoul Clinical Site, Seoul, 120-752, Korea, Republic of|Seoul Clinical Site, Seoul, 135-710, Korea, Republic of|Seoul Clinical Site, Seoul, 135-720, Korea, Republic of|Seoul Clinical Site, Seoul, 136-705, Korea, Republic of|Seoul Clinical Site, Seoul, 137-701, Korea, Republic of|Seoul Clinical Site, Seoul, 138-736, Korea, Republic of|Seoul Clinical Site, Seoul, 152-703, Korea, Republic of|Kaohsiung Clinical Site, Kaohsiung, 807, Taiwan|Kaohsiung Clinical Site, Kaohsiung, 833, Taiwan|Taichung Clinical Site, Taichung, 40447, Taiwan|Tainan Clinical Site, Tainan, 704, Taiwan|Taipei Clinical Site, Taipei, 10002, Taiwan|Taipei Clinical Site, Taipei, 112, Taiwan|Taipei Clinical Site, Taipei, 114, Taiwan|Taipei Clinical Site, Taipei, 116, Taiwan|Taoyuan Clinical Site, Taoyuan, 333, Taiwan",
